ReviewCurrent neurology and neuroscience reports2004
Diabetic neuropathy: clinical features, etiology, and therapy.
Review in Current neurology and neuroscience reports, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 34 citations in OpenAlex.
- Clinico-microbiological study and antibiotic resistance profile of mecA and ESBL gene prevalence in patients with diabetic foot infections.Experimental and therapeutic medicine · 2016Article
- Contemporary insights into painful diabetic neuropathy and treatment with spinal cord stimulation.Current pain and headache reports · 2012Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus is a common cause of peripheral nervous system disorders that manifest in a variety of clinical forms, many of which are often misdiagnosed. Over the past two decades, our understanding of the pathophysiology of diabetic nerve injury has improved remarkably through the elucidation of the important roles of the polyol pathway of glucose metabolism, oxidative injury, advanced glycosylation end-products, vascular insufficiency, and other mechanisms. A large number of clinical treatment trials based upon this abundant scientific data have met with limited success, but ongoing and future trials offer promise for more dramatic success in treating this common cause of morbidity and mortality in the diabetic population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.